Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models

類似資料

• Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma
  著者:: Yang, Xuran, 等
  出版事項: (2018)
• Notch pathway inhibition using PF-03084014, a γ-secretase inhibitor (GSI), enhances the anti-tumor effect of docetaxel in prostate cancer
  著者:: Cui, Di, 等
  出版事項: (2015)
• Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
  著者:: Kummar, Shivaani, 等
  出版事項: (2017)
• Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
  著者:: Locatelli, Marzia A., 等
  出版事項: (2016)
• Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib
  著者:: Zhang, Cathy C, 等
  出版事項: (2014)